Investing
Popular Now
Latest Posts
More Articles

Should You Buy Palantir Stock Today?
Palantir Technologies (PLTR +1.23%) has proven to be an extraordinary performer for those investors who entered early during the initial

StandardAero’s Carlyle Selloff Overshadows Solid Fundamentals
StandardAero (NYSE: SARO) has delivered an impressive performance, surging by 21.7% since the previous analysis, even as the S&P 500

Gold Price Update: February 17, 2026 Trends
Today, the price of gold has experienced a decline compared to the previous day, reflecting ongoing fluctuations in the precious

Broadcom: Your AI Boom Second Chance Post-Nvidia
As AI Priorities Evolve, Emerging Leaders Take Center Stage The landscape of artificial intelligence has undergone remarkable transformation with the

AI Hype vs Reality: Finance Job Cuts Exposed
AI is stifling hiring in the banking industry—and it could last for years Last year, in a letter addressed to

Impax US Sustainable Economy Fund Q4 2025 Review
Fund Overview The Impax US Sustainable Economy Fund employs a systematic investment approach, targeting large-cap companies in the United States

Buffett’s Last Moves: Sells Amazon, Apple, BofA; Buys NYT Stock Pre-Retirement
The Oracle of Omaha’s Final Quarter as Berkshire Hathaway CEO Quarterly Form 13F filings submitted to the Securities and Exchange

AppLovin Q4 Earnings: Prioritizing AppDiscovery ROAS Over Competition Noise
Summary AppLovin continues to hold a Strong Buy rating, accompanied by a price target of $605, even after delivering impressive

Enbridge Overvalued Like AI Tech Amid CapEx Risks (Hold)
Enbridge has recently announced its fourth-quarter earnings results, which proved to be quite strong overall. The company is maintaining a

Waterdrop: Strong Growth and Value in China’s InsurTech
Summary Waterdrop Inc. stands out by blending impressive expansion with consistent profitability, achieving a remarkable 38.4% increase in revenue alongside

Salesforce Stands Strong: SaaS Downturn Fears Overstated
The much-talked-about software apocalypse has significantly impacted Salesforce, pushing its stock to trade at a mere 15 times forward earnings.

$300 Buys 2 Biotech Stocks for Long-Term Gains
Promising Biotech Opportunities with Blockbuster Potential Two innovative biotechnology companies, each equipped with a single commercialized therapy, stand out due









































